Skip to the page

Data / Form D filings / NovaDerm Aid Fund Eta LLC

NovaDerm Aid Fund Eta LLC: Form D filing

NovaDerm Aid Fund Eta LLC, a biotechnology company in Dallas, TX, filed a Form D with the SEC in 2023. The latest, on April 17, 2023, reports $2 million sold of a $2 million offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4514 COLE AVENUE, SUITE 600, Dallas, TX, 75205
Phone
(214) 687-8437
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Nevada
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1973741

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 17, 2023New notice$2,000,000$2,000,00018Dec 13, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Geoffrey C. DietrichExecutive Officer
Biomed Management Alpha LLCDirector

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Apr 17, 2023 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what NovaDerm Aid Fund Eta LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.